Publications by authors named "Ghandour Fatme"

Hirschsprung's (HSCR) disease, also known as aganglionic megacolon, or congenital intestinal aganglionosis affects roughly 1 out of every 5000 newborns. It is a birth defect characterized by the partial or complete loss of ganglion cells in the myenteric and submucosal plexus of the distal intestine which leads to ineffective peristalsis, constipation, and obstruction. Clinical assessment and radiological observations might imply HSCR disease, but definitive diagnosis requires biopsy interpretation and confirmation of ganglion cell loss.

View Article and Find Full Text PDF

Intrahepatic cholangiocarcinoma is a primary liver malignancy with poor prognosis and limited treatment options. Lymphoepithelioma-like intrahepatic cholangiocarcinoma is an exceedingly rare variant of intrahepatic cholangiocarcinoma that histologically resembles nasopharyngeal carcinoma, previously known as lymphoepithelioma. It was first reported by Hsu et al in 1996 and they were able to show the presence of Epstein-Barr virus in tumor cells.

View Article and Find Full Text PDF

Encapsulated apocrine papilloma of the breast without myoepithelial cell markers is a rare occurrence. For its diagnosis, histopathological examination shows encapsulated apocrine papilloma lacking myoepithelial cell markers. To the best of our knowledge, this is the first documented case of an encapsulated apocrine papilloma entirely devoid of myoepithelial cell markers.

View Article and Find Full Text PDF
Article Synopsis
  • HHLA2 is an immune checkpoint associated with kidney cancer and other tumors, and understanding its expression regulation is key for developing targeted therapies.
  • HHLA2 expression is found in primary kidney tumors but decreases in vitro, while it can be induced in vivo under specific tumor microenvironment conditions.
  • Only certain cytokines like IL-10 and BMP4 can modestly enhance HHLA2 expression in immune cells, indicating complex regulation involving tumor and immune cell interactions.
View Article and Find Full Text PDF

Recent advances in our understanding of the molecular alterations underlying different types of renal cell carcinoma (RCC), as well as the implementation of immune checkpoint inhibitors in the treatment of patients with advanced disease, have significantly expanded the role of pathologists in the management of RCC patients and in the identification of predictive biomarkers that can guide patient treatment. In this chapter, we examine pathologists' evolving role in patient care and the development of precision medicine strategies for RCC.

View Article and Find Full Text PDF

Colonic carcinosarcoma is an extremely rare tumor composed of mixed malignant epithelial and mesenchymal cells. Due to its rarity, its pathogenesis is poorly understood, and there are no specific guidelines for its treatment.

View Article and Find Full Text PDF

Oncocytic Papillary Renal Cell Carcinoma (OPRCC) is a rare variant of renal cell carcinoma with overlapping characteristics type 1 and 2 of papillary renal carcinoma. Based on the literature, OPRCC is predominantly present in adult males. OPRCC has a specific genetic affiliation with the Fumarate Hydratase gene requiring all patients diagnosed with OPRCC to undergo genetic testing.

View Article and Find Full Text PDF

Sebaceous carcinoma of the breast is an extremely rare tumor. To the best of our knowledge only 15 cases have been reported in literature. Herein, we report a case of sebaceous carcinoma of the breast and describe the histopathologic features of sebaceous carcinoma of the breast in an elderly female.

View Article and Find Full Text PDF